Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | HTR6 | P50406 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28989835 | 0.98 | BCHE (0.58) | BCHEDRD2HTR6MTNR1AMTNR1B | |
| SCHEMBL27515867 | 0.98 | BCHE (0.58) | BCHEDRD2HTR6MTNR1AMTNR1B | |
| SCHEMBL28989836 | 0.98 | BCHE (0.58) | BCHEDRD2HTR6MTNR1AMTNR1B | |
| SCHEMBL19259383 | 0.98 | BCHE (0.58) | BCHEDRD2HTR6MTNR1AMTNR1B | |
| SCHEMBL28256253 | 0.98 | BCHE (0.58) | BCHEDRD2HTR6MTNR1AMTNR1B | |
| SCHEMBL9571237 | 0.98 | BCHE (0.58) | BCHEDRD2HTR6MTNR1AMTNR1B | |
| SCHEMBL29903265 | 0.97 | BCHE (0.56) | BCHEDRD2HTR6MTNR1AMTNR1B | |
| SCHEMBL27838111 | 0.95 | BCHE (0.60) | BCHEDRD2HTR6MTNR1AMTNR1B | |
| SCHEMBL6689910 | 0.90 | SIGMAR1 (0.55) | BCHESIGMAR1 | |
| SCHEMBL30364914 | 0.90 | SIGMAR1 (0.55) | BCHESIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109071439-B | Process for preparing 4-aminoindane derivatives and related aminoindane amides | I-F产品协作基金会 | 2022-07-15 | — | — | CN | claimed |
| US-11148995-B2 | Processes for preparation of 4-aminoindane compounds and related aminoindane amides | STICHTING I-F PRODUCT COLLABORATION (NL) | 2021-10-19 | — | — | US | claimed |
| US-20200231533-A1 | PROCESSES FOR PREPARATION OF 4-AMINOINDANE COMPOUNDS AND RELATED AMINOINDANE AMIDES | FMC IP TECHNOLOGY GMBH (CH) | 2020-07-23 | — | — | US | claimed |
| US-10640454-B2 | Processes for preparation of 4-aminoindane compounds and related aminoindane amides | STICHTING I-F PRODUCT COLLABORATION (NL) | 2020-05-05 | — | — | US | claimed |
| EP-3442944-B1 | PROCESS FOR THE PREPARATION OF 4-AMINOINDANE DERIVATIVES AND RELATED AMINOINDANE AMIDES | STICHTING I F PRODUCT COLLABORATION (NL) | 2020-04-15 | — | — | EP | claimed |
| US-20190119195-A1 | PROCESSES FOR PREPARATION OF 4-AMINOINDANE DERIVATIVES AND RELATED AMINOINDANE AMIDES | FMC IP TECHNOLOGY GMBH (CH) | 2019-04-25 | — | — | US | claimed |
| EP-3442944-A1 | PROCESS FOR THE PREPARATION OF 4-AMINOINDANE DERIVATIVES AND RELATED AMINOINDANE AMIDES | Stichting I-F Product Collaboration (NL) | 2019-02-20 | — | — | EP | claimed |
| WO-2017178868-A1 | PROCESS FOR THE PREPARATION OF 4-AMINOINDANE DERIVATIVES AND RELATED AMINOINDANE AMIDES | STICHTING I-F PRODUCT COLLABORATION (NL) | 2017-10-19 | — | — | WO | claimed |
| CN-1751031-A | HIV replication inhibiting pyrimidines and triazines | TIBOTEC PHARM LTD (IE) | 2006-03-22 | — | — | CN | claimed |
| US-11959010-B2 | Heat storage composition, heat storage member, electronic device, and manufacturing method of heat storage member | FUJIFILM CORPORATION (JP) | 2024-04-16 | — | — | US | disclosed |
| US-11851388-B2 | Compound of 1-acetyl-6-fluoro-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline | FMC AGRO SINGAPORE PTE. LTD. (SG) | 2023-12-26 | — | — | US | disclosed |
| CN-116354182-A | Reel body container and reel body | 富士胶片株式会社 | 2023-06-30 | — | — | CN | disclosed |
| CN-116354184-A | Rolling body | 富士胶片株式会社 | 2023-06-30 | — | — | CN | disclosed |
| CN-113727849-B | Heat storage member | 富士胶片株式会社 | 2023-06-30 | — | — | CN | disclosed |
| US-6653307-B2 | Such as N-(4-chlorobenzyl)-6-(4-morpholinylmethyl)-4-oxo-1-phenyl-1,4-dihydro-3-quinolinecarboxamide for treatment of herpes virus; viral DNA polymerase inhibitors | PHARMACIA & UPJOHN COMPANY | 2003-11-25 | — | — | US | disclosed |
| CN-1432001-A | 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | UPJOHN CO (US) | 2003-07-23 | — | — | CN | disclosed |
| EP-1292575-A2 | 1-ARYL-4-OXO-1,4-DIHYDRO-3-QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2003-03-19 | — | — | EP | disclosed |
| US-20020103220-A1 | 1-Aryl-4oxo-1,4-Dihydro-3-quinolinecarboxamides as antiviral agents | PHARMACIA & UPJOHN COMPANY | 2002-08-01 | — | — | US | disclosed |
| WO-2001098275-A2 | 1-ARYL-4-OXO-1,4-DIHYDRO-3-QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2001-12-27 | — | — | WO | disclosed |
| EP-0114385-B1 | ELECTRICAL INSULATING OIL AND OIL-FILLED ELECTRICAL APPLIANCES | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1987-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11851388-B2 | Compound of 1-acetyl-6-fluoro-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline | HDAC3, HDAC6, KAT2A | BCHE 2390/4885DRD2 2234/4885HTR6 462/4885 |
| US-10640454-B2 | Processes for preparation of 4-aminoindane compounds and related aminoindane amides | AADAT, ALDH7A1, AAAS | BCHE 539/4885DRD2 160/4885HTR6 257/4885 |
| US-20190119195-A1 | PROCESSES FOR PREPARATION OF 4-AMINOINDANE DERIVATIVES AND RELATED AMINOINDANE AMIDES | ALDH7A1, AADAT, AASDHPPT | BCHE 599/4885DRD2 164/4885HTR6 326/4885 |
| US-11148995-B2 | Processes for preparation of 4-aminoindane compounds and related aminoindane amides | AADAT, ALDH7A1, AAAS | BCHE 474/4885DRD2 287/4885HTR6 428/4885 |
| US-20020103220-A1 | 1-Aryl-4oxo-1,4-Dihydro-3-quinolinecarboxamides as antiviral agents | ZC3HAV1, IRF3, ZC3HAV1L | BCHE 4286/4885DRD2 4470/4885HTR6 4037/4885 |
| US-20200231533-A1 | PROCESSES FOR PREPARATION OF 4-AMINOINDANE COMPOUNDS AND RELATED AMINOINDANE AMIDES | AADAT, ALDH7A1, AAAS | BCHE 474/4885DRD2 287/4885HTR6 428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.